Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
#:"(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)"
topic_facet:"Medical Condition: COVID-19 MedDRA version: 23.0Level: PTClassification code 10051905Term: Coronavirus infectionSystem Organ Class: 10021881 - Infections and infestations;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]"
(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=%23%3A%22%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+COVID-19+MedDRA+version%3A+23.0Level%3A+PTClassification+code+10051905Term%3A+Coronavirus+infectionSystem+Organ+Class%3A+10021881+-+Infections+and+infestations%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Respiratory+Tract+Diseases+%5BC08%5D%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject
/vufind/Search/Results?filter%5B%5D=%23%3A%22%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+COVID-19+MedDRA+version%3A+23.0Level%3A+PTClassification+code+10051905Term%3A+Coronavirus+infectionSystem+Organ+Class%3A+10021881+-+Infections+and+infestations%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Respiratory+Tract+Diseases+%5BC08%5D%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=%23%3A%22%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+COVID-19+MedDRA+version%3A+23.0Level%3A+PTClassification+code+10051905Term%3A+Coronavirus+infectionSystem+Organ+Class%3A+10021881+-+Infections+and+infestations%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Respiratory+Tract+Diseases+%5BC08%5D%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject
PubPharm (12)
1
A phase I/III study to assess pre-exposure prophylaxis of AZD5156 in immunocompromised individuals : A Phase I/III Randomized, Double blind Study to Evaluate the Safety and Neutralizing Activity of AZD5156 for Pre-exposure Prophylaxis of COVID-19 in Participants with Conditions Causing Immune Impairment - SUPERNOVA
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
A phase I/III study to assess pre-exposure prophylaxis of AZD5156 in immunocompromised individuals : A Phase I/III Randomized, Double blind Study to Evaluate the Safety and Neutralizing Activity of AZD5156 for Pre-exposure Prophylaxis of COVID-19 in Participants with Conditions Causing Immune Impairment - SUPERNOVA
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
Phase III, double-blinded study using AZD7442 or Placebo for the prevention of COVID-19 disease in adults who have not been exposed to COVID-19 infection : A Phase III Randomized, Double-blind, Placebo-controlled, Multi-center Study in Adults to Determine the Safety and Efficacy of AZD7442, a Combination Product of Two Monoclonal Antibodies (AZD8895 and AZD1061), for Pre-exposure Prophylaxis of COVID-19 - Phase 3 Double-blind study of AZD7442 or Placebo for Pre-exposure Prophylaxis of COVID-19 in Adults
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
4
Phase III, double-blinded study using AZD7442 or Placebo for the prevention of COVID-19 disease in adults who have not been exposed to COVID-19 infection : A Phase III Randomized, Double-blind, Placebo-controlled, Multi-center Study in Adults to Determine the Safety and Efficacy of AZD7442, a Combination Product of Two Monoclonal Antibodies (AZD8895 and AZD1061), for Pre-exposure Prophylaxis of COVID-19 - Phase 3 Double-blind study of AZD7442 or Placebo for Pre-exposure Prophylaxis of COVID-19 in Adults
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
5
Phase 2b study, conducted in few medical centers, patients will be allocated randomly to receive active drug or placebo. The study will evaluate the efficacy and safety of the drug in patients with respiratory failure due to COVID-19. : A Phase 2b Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study, Evaluating Efficacy and Safety of Allocetra-OTS in Patients with Severe or Critical COVID-19 with Associated Acute Respiratory Distress Syndrome
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
6
Phase 2b study, conducted in few medical centers, patients will be allocated randomly to receive active drug or placebo. The study will evaluate the efficacy and safety of the drug in patients with respiratory failure due to COVID-19. : A Phase 2b Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study, Evaluating Efficacy and Safety of Allocetra-OTS in Patients with Severe or Critical COVID-19 with Associated Acute Respiratory Distress Syndrome
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
7
Phase III, double-blinded study using AZD7442 or Placebo for the prevention of COVID-19 disease in adults who have not been exposed to COVID-19 infection : A Phase III Randomized, Double-blind, Placebo-controlled, Multi-center Study in Adults to Determine the Safety and Efficacy of AZD7442, a Combination Product of Two Monoclonal Antibodies (AZD8895 and AZD1061), for Pre-exposure Prophylaxis of COVID-19 - Phase 3 Double-blind study of AZD7442 or Placebo for Pre-exposure Prophylaxis of COVID-19 in Adults
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
8
Phase III, double-blinded study using AZD7442 or Placebo for the prevention of COVID-19 disease in adults who have not been exposed to COVID-19 infection : A Phase III Randomized, Double-blind, Placebo-controlled, Multi-center Study in Adults to Determine the Safety and Efficacy of AZD7442, a Combination Product of Two Monoclonal Antibodies (AZD8895 and AZD1061), for Pre-exposure Prophylaxis of COVID-19 - Phase 3 Double-blind study of AZD7442 or Placebo for Pre-exposure Prophylaxis of COVID-19 in Adults
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
9
Phase III, double-blinded study using AZD7442 or Placebo for the prevention of COVID-19 disease in adults who have been potentially exposed to COVID-19. : A Phase III Randomized, Double-blind, Placebo-controlled, Multi-center Study in Adults to Determine the Safety and Efficacy of AZD7442, a Combination Product of Two Monoclonal Antibodies (AZD8895 and AZD1061), for Post-exposure Prophylaxis of COVID-19 - Phase 3 Double blind Study of AZD7442 or Placebo for Post-exposure Prophylaxis of COVID-19 in Adults
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
10
Phase III, double-blinded study using AZD7442 or Placebo for the prevention of COVID-19 disease in adults who have been potentially exposed to COVID-19. : A Phase III Randomized, Double-blind, Placebo-controlled, Multi-center Study in Adults to Determine the Safety and Efficacy of AZD7442, a Combination Product of Two Monoclonal Antibodies (AZD8895 and AZD1061), for Post-exposure Prophylaxis of COVID-19 - Phase 3 Double blind Study of AZD7442 or Placebo for Post-exposure Prophylaxis of COVID-19 in Adults
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Filter aufheben
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Medical Condition: COVID-19 MedDRA version: 23.0Level: PTClassification code 10051905Term: Coronavirus infectionSystem Organ Class: 10021881 - Infections and infestations;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
Medienart
12
Aufsätze
12
E-Artikel
12
E-Ressourcen
Zeitschriftentitel
12
WHO International Clinical Trials Registry Plat...
Thema
12
610
Medical Condition: COVID-19 MedDRA version: 23....
12
Recruitment Status: Authorised-recruitment may ...
12
Study Type: Interventional
10
Phase: Phase 3
2
Phase: Phase 2
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2
2023
2
2022
6
2021
2
2020
Erscheinungsjahr(e)
Von:
Bis:
Sprache
12
Englisch
Haven't found what you're looking for?
Wird geladen...